Skip to main content
SpringerLink
Log in

Alzheimer’s Disease and Other Neurodegenerative Disorders

  • Chapter
  • First Online:
Handbook of Clinical Nutrition and Aging

Part of the book series: Nutrition and Health ((NH))

  • 2823 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet 2006; 368(9533):387–403.

    Article  PubMed  CAS  Google Scholar 

  2. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366(9503):2112–7.

    Article  PubMed  Google Scholar 

  3. Moller HJ, Graeber MB. The case described by Alois Alzheimer in 1911. Historical and conceptual perspectives based on the clinical record and neurohistological sections. Eur Arch Psychiatry Clin Neurosci 1998; 248(3):111–22.

    Article  PubMed  CAS  Google Scholar 

  4. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297(5580):353–6.

    Article  PubMed  CAS  Google Scholar 

  5. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349(6311):704–6.

    Article  PubMed  CAS  Google Scholar 

  6. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375(6534):754–60.

    Article  PubMed  CAS  Google Scholar 

  7. Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269(5226):973–7.

    Article  PubMed  CAS  Google Scholar 

  8. Games D, Adams D, Alessandrini R, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 1995; 373(6514):523–7.

    Article  PubMed  CAS  Google Scholar 

  9. Hsiao K, Chapman P, Nilsen S, et al. Correlative memory deficits, A beta elevation, and amyloid plaques in transgenic mice. Science 1996; 274(5284):99–102.

    Article  PubMed  CAS  Google Scholar 

  10. Jankowsky JL, Fadale DJ, Anderson J, et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 2004; 13(2):159–70.

    Article  PubMed  CAS  Google Scholar 

  11. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer's disease. Annu Rev Neurosci 1996; 19:53–77.

    Article  PubMed  CAS  Google Scholar 

  12. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994; 7(2):180–4.

    Article  PubMed  CAS  Google Scholar 

  13. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261(5123):921–3.

    Article  PubMed  CAS  Google Scholar 

  14. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993; 342(8873):697–9.

    Article  PubMed  CAS  Google Scholar 

  15. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997; 278(16):1349–56.

    Article  PubMed  CAS  Google Scholar 

  16. Meyer MR, Tschanz JT, Norton MC, et al. APOE genotype predicts when – not whether – one is predisposed to develop Alzheimer disease. Nat Genet 1998; 19(4):321–2.

    Article  PubMed  CAS  Google Scholar 

  17. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994; 17(12):525–30.

    Article  PubMed  CAS  Google Scholar 

  18. Bales KR, Verina T, Dodel RC, et al. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet 1997; 17(3):263–4.

    Article  PubMed  CAS  Google Scholar 

  19. Holtzman DM, Bales KR, Tenkova T, et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2000; 97(6):2892–7.

    Google Scholar 

  20. Tanzi RE, Bertram L. New frontiers in Alzheimer's disease genetics. Neuron 2001; 32(2):181–4.

    Article  PubMed  CAS  Google Scholar 

  21. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann NY Acad Sci 2003; 991:1–14.

    Article  PubMed  CAS  Google Scholar 

  22. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002; 125(Pt 4):861–70.

    Article  PubMed  Google Scholar 

  23. Farrer MJ. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 2006; 7(4):306–18.

    Article  PubMed  CAS  Google Scholar 

  24. Chen L, Feany MB. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat Neurosci 2005; 8(5):657–63.

    Article  PubMed  CAS  Google Scholar 

  25. Shimura H, Hattori N, Kubo S, et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 2000; 25(3):302–5.

    Article  PubMed  CAS  Google Scholar 

  26. Maraganore DM, de Andrade M, Lesnick TG, et al. High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 2005; 77(5):685–93.

    Article  PubMed  CAS  Google Scholar 

  27. Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet 2007; 369(9578):2031–41.

    Article  PubMed  CAS  Google Scholar 

  28. Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 2006; 7(9):710–23.

    Article  PubMed  CAS  Google Scholar 

  29. Dunckley T, Huentelman MJ, Craig DW, et al. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J Med 2007; 357(8):775–88.

    Article  PubMed  CAS  Google Scholar 

  30. Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004; 27:723–49.

    Article  PubMed  CAS  Google Scholar 

  31. Walker FO. Huntington's disease. Lancet 2007; 369(9557):218–28.

    Article  PubMed  CAS  Google Scholar 

  32. Takano H, Cancel G, Ikeuchi T, et al. Close associations between prevalences of dominantly inherited spinocerebellar ataxias with CAG-repeat expansions and frequencies of large normal CAG alleles in Japanese and Caucasian populations. Am J Hum Genet 1998; 63(4):1060–6.

    Article  PubMed  CAS  Google Scholar 

  33. Wright HH, Still CN, Abramson RK. Huntington's disease in black kindreds in South Carolina. Arch Neurol 1981; 38(7):412–4.

    Article  PubMed  CAS  Google Scholar 

  34. Gusella JF, Wexler NS, Conneally PM, et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983; 306(5940):234–8.

    Article  PubMed  CAS  Google Scholar 

  35. Wexler NS, Lorimer J, Porter J, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci USA 2004; 101(10):3498–503.

    Google Scholar 

  36. Kuller LH. Nutrition, lipids, and cardiovascular disease. Nutr Rev 2006; 64(2 Pt 2):S15–26.

    Article  PubMed  Google Scholar 

  37. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 1997; 42(5):776–82.

    Article  PubMed  CAS  Google Scholar 

  38. Luchsinger JA, Tang MX, Shea S, Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch Neurol 2002; 59(8):1258–63.

    Article  PubMed  Google Scholar 

  39. Laitinen MH, Ngandu T, Rovio S, et al. Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study. Dement Geriatr Cogn Disord 2006; 22(1):99–107.

    Article  PubMed  CAS  Google Scholar 

  40. Refolo LM, Malester B, LaFrancois J, et al. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 2000; 7(4):321–31.

    Article  PubMed  CAS  Google Scholar 

  41. Shie FS, Jin LW, Cook DG, Leverenz JB, LeBoeuf RC. Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice. Neuroreport 2002; 13(4):455–9.

    Article  PubMed  CAS  Google Scholar 

  42. Levin-Allerhand JA, Lominska CE, Smith JD. Increased amyloid-levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet. J Nutr Health Aging 2002; 6(5):315–9.

    PubMed  CAS  Google Scholar 

  43. Li L, Cao D, Garber DW, Kim H, Fukuchi K. Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease. Am J Pathol 2003; 163(6):2155–64.

    Article  PubMed  CAS  Google Scholar 

  44. Connor WE, Connor SL. The importance of fish and docosahexaenoic acid in Alzheimer disease. Am J Clin Nutr 2007; 85(4):929–30.

    PubMed  CAS  Google Scholar 

  45. Tully AM, Roche HM, Doyle R, et al. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br J Nutr 2003; 89(4):483–9.

    Article  PubMed  CAS  Google Scholar 

  46. Soderberg M, Edlund C, Kristensson K, Dallner G. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 1991; 26(6):421–5.

    Article  PubMed  CAS  Google Scholar 

  47. Morris MC, Evans DA, Bienias JL, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003; 60(7):940–6.

    Article  PubMed  Google Scholar 

  48. Schaefer EJ, Bongard V, Beiser AS, et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 2006; 63(11):1545–50.

    Article  PubMed  Google Scholar 

  49. van Gelder BM, Tijhuis M, Kalmijn S, Kromhout D. Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study. Am J Clin Nutr 2007; 85(4):1142–7.

    PubMed  Google Scholar 

  50. Beydoun MA, Kaufman JS, Satia JA, Rosamond W, Folsom AR. Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 2007; 85(4):1103–11.

    PubMed  CAS  Google Scholar 

  51. Hashimoto M, Tanabe Y, Fujii Y, Kikuta T, Shibata H, Shido O. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J Nutr 2005; 135(3):549–55.

    PubMed  CAS  Google Scholar 

  52. Calon F, Lim GP, Yang F, et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004; 43(5):633–45.

    Article  PubMed  CAS  Google Scholar 

  53. Lim GP, Calon F, Morihara T, et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 2005; 25(12): 3032–40.

    Article  PubMed  CAS  Google Scholar 

  54. Green KN, Martinez-Coria H, Khashwji H, et al. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci 2007; 27(16):4385–95.

    Article  PubMed  CAS  Google Scholar 

  55. Blok WL, Katan MB, van der Meer JW. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J Nutr 1996; 126(6):1515–33.

    PubMed  CAS  Google Scholar 

  56. Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS. Fish consumption and cognitive decline with age in a large community study. Arch Neurol 2005; 62(12):1849–53.

    Article  PubMed  Google Scholar 

  57. Lichtenstein AH, Appel LJ, Brands M, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006; 114(1):82–96.

    Article  PubMed  Google Scholar 

  58. Anderson C, Checkoway H, Franklin GM, Beresford S, Smith-Weller T, Swanson PD. Dietary factors in Parkinson's disease: the role of food groups and specific foods. Mov Disord 1999; 14(1):21–7.

    Article  PubMed  CAS  Google Scholar 

  59. Logroscino G, Marder K, Cote L, Tang MX, Shea S, Mayeux R. Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study. Ann Neurol 1996; 39(1):89–94.

    Article  PubMed  CAS  Google Scholar 

  60. Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A. Dietary intakes of fat and risk of Parkinson's disease. Am J Epidemiol 2003; 157(11):1007–14.

    Article  PubMed  Google Scholar 

  61. Powers KM, Smith-Weller T, Franklin GM, Longstreth WT, Jr., Swanson PD, Checkoway H. Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology 2003; 60(11):1761–6.

    Article  PubMed  CAS  Google Scholar 

  62. Abbott RD, Ross GW, White LR, et al. Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study. J Neurol 2003; 250(Suppl 3):III30–9.

    PubMed  Google Scholar 

  63. de Lau LM, Bornebroek M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study. Neurology 2005; 64(12): 2040–5.

    Article  PubMed  CAS  Google Scholar 

  64. Veldink JH, Kalmijn S, Groeneveld GJ, et al. Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2007; 78(4):367–71.

    Article  PubMed  CAS  Google Scholar 

  65. Puri BK, Leavitt BR, Hayden MR, et al. Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial. Neurology 2005; 65(2):286–92.

    Article  PubMed  CAS  Google Scholar 

  66. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004; 79(4):537–43.

    PubMed  CAS  Google Scholar 

  67. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA 2004; 291(23):2847–50.

    Article  PubMed  CAS  Google Scholar 

  68. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999–2000. JAMA 2002; 288(14):1728–32.

    Article  PubMed  Google Scholar 

  69. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997; 337(13):869–73.

    Article  PubMed  CAS  Google Scholar 

  70. Grundy SM. Multifactorial causation of obesity: implications for prevention. Am J Clin Nutr 1998; 67(3 Suppl):563S–72S.

    PubMed  CAS  Google Scholar 

  71. Haan MN. Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease. Nat Clin Pract Neurol 2006; 2(3):159–66.

    Article  PubMed  CAS  Google Scholar 

  72. Leibson CL, Rocca WA, Hanson VA, et al. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 1997; 145(4):301–8.

    Article  PubMed  CAS  Google Scholar 

  73. Stolk RP, Breteler MM, Ott A, et al. Insulin and cognitive function in an elderly population: the Rotterdam Study. Diabetes Care 1997; 20(5):792–5.

    Article  PubMed  CAS  Google Scholar 

  74. Craft S, Watson GS. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 2004; 3(3):169–78.

    Article  PubMed  CAS  Google Scholar 

  75. Mungas D, Cooper JK, Weiler PG, Gietzen D, Franzi C, Bernick C. Dietary preference for sweet foods in patients with dementia. J Am Geriatr Soc 1990; 38(9):999–1007.

    PubMed  CAS  Google Scholar 

  76. Greenwood CE, Tam C, Chan M, Young KW, Binns MA, van Reekum R. Behavioral disturbances, not cognitive deterioration, are associated with altered food selection in seniors with Alzheimer's disease. J Gerontol A Biol Sci Med Sci 2005; 60(4):499–505.

    Article  PubMed  Google Scholar 

  77. Young KW, Greenwood CE, van Reekum R, Binns MA. A randomized, crossover trial of high-carbohydrate foods in nursing home residents with Alzheimer's disease: associations among intervention response, body mass index, and behavioral and cognitive function. J Gerontol A Biol Sci Med Sci 2005; 60(8):1039–45.

    Article  PubMed  Google Scholar 

  78. Luchsinger JA, Tang MX, Mayeux R. Glycemic load and risk of Alzheimer's disease. J Nutr Health Aging 2007; 11(3):238–41.

    PubMed  CAS  Google Scholar 

  79. Cao D, Lu H, Lewis TL, Li L. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer's disease. J Biol Chem 2007;282(50):36275–82.

    Google Scholar 

  80. Abbott RD, Ross GW, White LR, et al. Midlife adiposity and the future risk of Parkinson's disease. Neurology 2002; 59(7):1051–7.

    Article  PubMed  CAS  Google Scholar 

  81. Vanitallie TB, Nonas C, Di Rocco A, Boyar K, Hyams K, Heymsfield SB. Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. Neurology 2005; 64(4):728–30.

    Article  PubMed  CAS  Google Scholar 

  82. Reyes ET, Perurena OH, Festoff BW, Jorgensen R, Moore WV. Insulin resistance in amyotrophic lateral sclerosis. J Neurol Sci 1984; 63(3):317–24.

    Article  PubMed  CAS  Google Scholar 

  83. Hubbard RW, Will AD, Peterson GW, Sanchez A, Gillan WW, Tan SA. Elevated plasma glucagon in amyotrophic lateral sclerosis. Neurology 1992; 42(8):1532–4.

    Article  PubMed  CAS  Google Scholar 

  84. Podolsky S, Leopold NA, Sax DS. Increased frequency of diabetes mellitus in patients with Huntington's chorea. Lancet 1972; 1(7765):1356–8.

    Article  PubMed  CAS  Google Scholar 

  85. Eikelboom JW, Lonn E, Genest J, Jr, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999; 131(5):363–75.

    PubMed  CAS  Google Scholar 

  86. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004; 291(5):565–75.

    Article  PubMed  CAS  Google Scholar 

  87. Morris MS. Homocysteine and Alzheimer's disease. Lancet Neurol 2003; 2(7):425–8.

    Article  PubMed  CAS  Google Scholar 

  88. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346(7):476–83.

    Article  PubMed  CAS  Google Scholar 

  89. Snowdon DA, Tully CL, Smith CD, Riley KP, Markesbery WR. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. Am J Clin Nutr 2000; 71(4):993–8.

    PubMed  CAS  Google Scholar 

  90. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55(11): 1449–55.

    Article  PubMed  CAS  Google Scholar 

  91. Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B, Fratiglioni L. Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology 2001; 56(9):1188–94.

    Article  PubMed  CAS  Google Scholar 

  92. Nilsson K, Gustafson L, Hultberg B. Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry 2001; 16(6):609–14.

    Article  PubMed  CAS  Google Scholar 

  93. Eastley R, Wilcock GK, Bucks RS. Vitamin B12 deficiency in dementia and cognitive impairment: the effects of treatment on neuropsychological function. Int J Geriatr Psychiatry 2000; 15(3):226–33.

    Article  PubMed  CAS  Google Scholar 

  94. Kwok T, Tang C, Woo J, Lai WK, Law LK, Pang CP. Randomized trial of the effect of supplementation on the cognitive function of older people with subnormal cobalamin levels. Int J Geriatr Psychiatry 1998; 13(9):611–6.

    Article  PubMed  CAS  Google Scholar 

  95. Crystal HA, Ortof E, Frishman WH, Gruber A, Hershman D, Aronson M. Serum vitamin B12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx Longitudinal Aging Study. J Am Geriatr Soc 1994; 42(9):933–6.

    PubMed  CAS  Google Scholar 

  96. Luchsinger JA, Tang MX, Miller J, Green R, Mayeux R. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol 2007; 64(1):86–92.

    Article  PubMed  Google Scholar 

  97. Malouf M, Grimley EJ, Areosa SA. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev 2003(4):CD004514.

    Google Scholar 

  98. Malouf R, Grimley EJ, Areosa SA. Vitamin B12 for cognition. Cochrane Database Syst Rev 2003(3):CD004326.

    Google Scholar 

  99. Malouf R, Grimley Evans J. The effect of vitamin B6 on cognition. Cochrane Database Syst Rev 2003(4):CD004393.

    Google Scholar 

  100. Ho PI, Ortiz D, Rogers E, Shea TB. Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res 2002; 70(5):694–702.

    Article  PubMed  CAS  Google Scholar 

  101. Kruman II, Kumaravel TS, Lohani A, et al. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 2002; 22(5):1752–62.

    PubMed  CAS  Google Scholar 

  102. Kuhn W, Roebroek R, Blom H, et al. Elevated plasma levels of homocysteine in Parkinson's disease. Eur Neurol 1998; 40(4):225–7.

    Article  PubMed  CAS  Google Scholar 

  103. Muller T, Werne B, Fowler B, Kuhn W. Nigral endothelial dysfunction, homocysteine, and Parkinson's disease. Lancet 1999; 354(9173):126–7.

    Article  PubMed  CAS  Google Scholar 

  104. de Lau LM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM. Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease. Neurology 2006; 67(2):315–8.

    Article  PubMed  CAS  Google Scholar 

  105. Sung JJ, Kim HJ, Choi-Kwon S, Lee J, Kim M, Lee KW. Homocysteine induces oxidative cytotoxicity in Cu,Zn-superoxide dismutase mutant motor neuronal cell. Neuroreport 2002; 13(4):377–81.

    Article  PubMed  CAS  Google Scholar 

  106. Chung YH, Hong JJ, Shin CM, Joo KM, Kim MJ, Cha CI. Immunohistochemical study on the distribution of homocysteine in the central nervous system of transgenic mice expressing a human Cu/Zn SOD mutation. Brain Res 2003; 967(1–2):226–34.

    Article  PubMed  CAS  Google Scholar 

  107. Zoccolella S, Martino D, Defazio G, Lamberti P, Livrea P. Hyperhomocysteinemia in movement disorders: current evidence and hypotheses. Curr Vasc Pharmacol 2006; 4(3):237–43.

    Article  PubMed  CAS  Google Scholar 

  108. Reynolds A, Laurie C, Lee Mosley R, Gendelman HE. Oxidative stress and the pathogenesis of neurodegenerative disorders. Int Rev Neurobiol 2007; 82:297–325.

    Article  PubMed  CAS  Google Scholar 

  109. Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann NY Acad Sci 2004; 1012:153–63.

    Article  PubMed  CAS  Google Scholar 

  110. Butterfield DA, Castegna A, Drake J, Scapagnini G, Calabrese V. Vitamin E and neurodegenerative disorders associated with oxidative stress. Nutr Neurosci 2002; 5(4):229–39.

    Article  PubMed  CAS  Google Scholar 

  111. Pitchumoni SS, Doraiswamy PM. Current status of antioxidant therapy for Alzheimer's disease. J Am Geriatr Soc 1998; 46(12):1566–72.

    PubMed  CAS  Google Scholar 

  112. Masaki KH, Losonczy KG, Izmirlian G, et al. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 2000; 54(6):1265–72.

    Article  PubMed  CAS  Google Scholar 

  113. Grodstein F, Chen J, Willett WC. High-dose antioxidant supplements and cognitive function in community-dwelling elderly women. Am J Clin Nutr 2003; 77(4):975–84.

    PubMed  CAS  Google Scholar 

  114. Zandi PP, Anthony JC, Khachaturian AS, et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol 2004; 61(1):82–8.

    Article  PubMed  Google Scholar 

  115. Morris MC, Evans DA, Bienias JL, Tangney CC, Wilson RS. Vitamin E and cognitive decline in older persons. Arch Neurol 2002; 59(7):1125–32.

    Article  PubMed  Google Scholar 

  116. Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002; 287(24):3223–9.

    Article  PubMed  CAS  Google Scholar 

  117. Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 2002; 287(24):3230–7.

    Article  PubMed  CAS  Google Scholar 

  118. Fukao A, Tsubono Y, Kawamura M, et al. The independent association of smoking and drinking with serum beta-carotene levels among males in Miyagi, Japan. Int J Epidemiol 1996; 25(2):300–6.

    Article  PubMed  CAS  Google Scholar 

  119. Luchsinger JA, Tang MX, Shea S, Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 2003; 60(2):203–8.

    Article  PubMed  Google Scholar 

  120. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease cooperative study. N Engl J Med 1997; 336(17):1216–22.

    Article  PubMed  CAS  Google Scholar 

  121. Etminan M, Gill SS, Samii A. Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis. Lancet Neurol 2005; 4(6):362–5.

    Article  PubMed  CAS  Google Scholar 

  122. Gurney ME, Cutting FB, Zhai P, et al. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 1996; 39(2):147–57.

    Article  PubMed  CAS  Google Scholar 

  123. Desnuelle C, Dib M, Garrel C, Favier A. A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group. Amyotroph Lateral Scler Other Motor Neuron Disord 2001; 2(1):9–18.

    Article  PubMed  CAS  Google Scholar 

  124. Vyth A, Timmer JG, Bossuyt PM, Louwerse ES, de Jong JM. Survival in patients with amyotrophic lateral sclerosis, treated with an array of antioxidants. J Neurol Sci 1996; 139(Suppl):99–103.

    Article  PubMed  CAS  Google Scholar 

  125. Peyser CE, Folstein M, Chase GA, et al. Trial of d-alpha-tocopherol in Huntington's disease. Am J Psychiatry 1995; 152(12):1771–5.

    PubMed  CAS  Google Scholar 

  126. Esposito E, Rotilio D, Di Matteo V, Di Giulio C, Cacchio M, Algeri S. A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Neurobiol Aging 2002; 23(5):719–35.

    Article  PubMed  CAS  Google Scholar 

  127. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003; 348(26):2599–608.

    Article  PubMed  Google Scholar 

  128. Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 2006; 59(6):912–21.

    Article  PubMed  Google Scholar 

  129. Panza F, Solfrizzi V, Colacicco AM, et al. Mediterranean diet and cognitive decline. Public Health Nutr 2004; 7(7):959–63.

    Article  PubMed  CAS  Google Scholar 

  130. Knoops KT, de Groot LC, Kromhout D, et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 2004; 292(12):1433–9.

    Article  PubMed  Google Scholar 

  131. Scarmeas N, Luchsinger JA, Mayeux R, Stern Y. Mediterranean diet and Alzheimer disease mortality. Neurology 2007; 69(11):1084–93.

    Article  PubMed  Google Scholar 

  132. Bailey RL, Gutschall MD, Mitchell DC, Miller CK, Lawrence FR, Smiciklas-Wright H. Comparative strategies for using cluster analysis to assess dietary patterns. J Am Diet Assoc 2006; 106(8):1194–200.

    Article  PubMed  Google Scholar 

  133. Kant AK. Dietary patterns and health outcomes. J Am Diet Assoc 2004; 104(4):615–35.

    Article  PubMed  Google Scholar 

  134. Weindruch R, Sohal RS. Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N Engl J Med 1997; 337(14):986–94.

    Article  PubMed  CAS  Google Scholar 

  135. Patel NV, Gordon MN, Connor KE, et al. Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models. Neurobiol Aging 2005; 26(7):995–1000.

    Article  PubMed  CAS  Google Scholar 

  136. Wang J, Ho L, Qin W, et al. Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. Faseb J 2005; 19(6):659–61.

    PubMed  Google Scholar 

  137. Halagappa VK, Guo Z, Pearson M, et al. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol Dis 2007; 26(1):212–20.

    Article  PubMed  CAS  Google Scholar 

  138. Mattson MP. Energy intake, meal frequency, and health: a neurobiological perspective. Annu Rev Nutr 2005; 25:237–60.

    Article  PubMed  CAS  Google Scholar 

  139. Mattson MP, Cutler RG, Camandola S. Energy intake and amyotrophic lateral sclerosis. Neuromolecular Med 2007; 9(1):17–20.

    Article  PubMed  CAS  Google Scholar 

  140. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34(7):939–44.

    Article  PubMed  CAS  Google Scholar 

  141. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, et al. Weight loss in Alzheimer disease. Am J Clin Nutr 2000; 71(2):637S–42S.

    PubMed  CAS  Google Scholar 

  142. Wang SY, Fukagawa N, Hossain M, Ooi WL. Longitudinal weight changes, length of survival, and energy requirements of long-term care residents with dementia. J Am Geriatr Soc 1997; 45(10):1189–95.

    PubMed  CAS  Google Scholar 

  143. White H, Pieper C, Schmader K, Fillenbaum G. Weight change in Alzheimer's disease. J Am Geriatr Soc 1996; 44(3):265–72.

    PubMed  CAS  Google Scholar 

  144. White H, Pieper C, Schmader K. The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis. J Am Geriatr Soc 1998; 46(10):1223–7.

    PubMed  CAS  Google Scholar 

  145. Stewart R, Masaki K, Xue QL, et al. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 2005; 62(1):55–60.

    Article  PubMed  Google Scholar 

  146. Johnson DK, Wilkins CH, Morris JC. Accelerated weight loss may precede diagnosis in Alzheimer disease. Arch Neurol 2006; 63(9):1312–7.

    Article  PubMed  Google Scholar 

  147. Feldman H, Scheltens P, Scarpini E, et al. Behavioral symptoms in mild cognitive impairment. Neurology 2004; 62(7):1199–201.

    Article  PubMed  CAS  Google Scholar 

  148. Jack CR, Jr., Petersen RC, Xu Y, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000; 55(4):484–89.

    Article  PubMed  Google Scholar 

  149. Grundman M, Corey-Bloom J, Jernigan T, Archibald S, Thal LJ. Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy. Neurology 1996; 46(6):1585–91.

    Article  PubMed  CAS  Google Scholar 

  150. Vanhanen M, Kivipelto M, Koivisto K, et al. APOE-epsilon4 is associated with weight loss in women with AD: a population-based study. Neurology 2001; 56(5):655–9.

    Article  PubMed  CAS  Google Scholar 

  151. Peskind ER, Wilkinson CW, Petrie EC, Schellenberg GD, Raskind MA. Increased CSF cortisol in AD is a function of APOE genotype. Neurology 2001; 56(8):1094–8.

    Article  PubMed  CAS  Google Scholar 

  152. Grundman M. Weight loss in the elderly may be a sign of impending dementia. Arch Neurol 2005; 62(1):20–2.

    Article  PubMed  Google Scholar 

  153. Logroscino G, Sesso HD, Paffenbarger RS, Jr., Lee IM. Body mass index and risk of Parkinson's disease: a prospective cohort study. Am J Epidemiol 2007; 166(10):1186–90.

    Article  PubMed  Google Scholar 

  154. Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A. Weight loss in Parkinson's disease. Ann Neurol 2003; 53(5):676–9.

    Article  PubMed  Google Scholar 

  155. Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA. Parkinson's disease is associated with hippocampal atrophy. Mov Disord 2003; 18(7):784–90.

    Article  PubMed  Google Scholar 

  156. Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr 1996; 63(1):130–7.

    PubMed  CAS  Google Scholar 

  157. Desport JC, Preux PM, Magy L, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr 2001; 74(3):328–34.

    PubMed  CAS  Google Scholar 

  158. van der Burg JM, Bacos K, Wood NI, et al. Increased metabolism in the R6/2 mouse model of Huntington's disease. Neurobiol Dis 2008;29(1):41–51.

    Google Scholar 

  159. Djousse L, Knowlton B, Cupples LA, Marder K, Shoulson I, Myers RH. Weight loss in early stage of Huntington's disease. Neurology 2002; 59(9):1325–30.

    Article  PubMed  CAS  Google Scholar 

  160. Gaba AM, Zhang K, Marder K, Moskowitz CB, Werner P, Boozer CN. Energy balance in early-stage Huntington disease. Am J Clin Nutr 2005; 81(6):1335–41.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Alabama at Birmingham, Birmingham, AL, England

    Ling Li & Terry L. Lewis

Authors
  1. Ling Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Terry L. Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Center for the Study of Aging &, Human Development, Duke University Medical Center, Durham, 27710, USA

    Connie W. Bales

  2. Div. Gerontology, Geriatrics &, Palliative Medicine, University of Alabama, Birmingham, 19th Street South 933, Birmingham, 35294, USA

    Christine S. Ritchie

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Li, L., Lewis, T.L. (2009). Alzheimer’s Disease and Other Neurodegenerative Disorders. In: Bales, C., Ritchie, C. (eds) Handbook of Clinical Nutrition and Aging. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-385-5_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-385-5_25

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-384-8

  • Online ISBN: 978-1-60327-385-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation